arrow
S

Simon Thom

university college london
H指数:67
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fibrinogen-mimicking, multiarm nanovesicles for human thrombus-specific delivery of tissue plasminogen activator and targeted thrombolytic therapy

模拟纤维蛋白原的多臂纳米囊泡,用于组织纤溶酶原激活剂的人血栓特异性递送和靶向溶栓治疗

2021-06-0444
OAAI
Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease The Stress Echocardiography-Stratified Analysis of ORBITA
2019-12-1052
OAAI
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial
2019-10-0124
OAAI
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (vol 50, pg 1412, 2018)

超过100万人的遗传分析确定了535个与血压性状相关的新基因座 (第50卷,1412页,2018)

2018-11-1415
OAAI
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA
2018-10-2383
OAAI
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

超过100万人的遗传分析确定了535个与血压特征相关的新基因座

2018-09-17885
OAAI
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka A Randomized Clinical Trial
2018-08-14126
OAAI
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials
HEART
IF4.4
2018-06-2846
OA
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

在盎格鲁-斯堪的纳维亚心脏结局试验 (ASCOT) 中,PPARGC1B和CNTN4的遗传变异与血栓素A2形成和无心血管事件生存率相关

2018-02-015
OAAI